Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Colorcon
Teva
Chubb
Chinese Patent Office

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 9,468,643

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,468,643
Title:PDE5 inhibitor compositions and methods for immunotherapy
Abstract: The invention features methods and compositions featuring a PDE5 inhibitor for treating or preventing immunological-mediated disease in a subject.
Inventor(s): Borrello; Ivan M. (Baltimore, MD), Serafini; Paolo (Miami Shores, FL), Noonan; Kimberly A. (Baltimore, MD), Bronte; Vincenzo (Abano Terme, IT)
Assignee: The Johns Hopkins University (Baltimore, MD)
Application Number:14/281,363
Patent Claims:see list of patent claims

Details for Patent 9,468,643

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up The Johns Hopkins University (Baltimore, MD) 2025-01-07 RX Orphan search
Sigma Tau ONCASPAR pegaspargase VIAL 103411 001 1994-02-01 ➤ Sign Up The Johns Hopkins University (Baltimore, MD) 2025-01-07 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up The Johns Hopkins University (Baltimore, MD) 2025-01-07 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Citi
Federal Trade Commission
Merck
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.